BAVIS_1170x120_1-20

Dr. Reddy’s rolls out aspirin and extended-release dipyridamole capsules

Print Friendly, PDF & Email

PRINCETON, N.J. — Dr. Reddy’s Laboratories Ltd. recently announced the launch of aspirin and extended-release dipyridamole capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) capsules in the United States market from the U.S. Food and Drug Administration.

The Aggrenox brand and generic had U.S. sales of approximately $182 million MAT for the most recent twelve months ending in October 2018 according to IMS Health.

Dr. Reddy’s Aspirin and Extended-Release Dipyridamole Capsules is available in 25 mg/200 mg strength with 60 count bottle size.


NT_728x90_10-3-18

TRP_728x90_12-19-19

Comments are closed.